Core Insights - Carlsmed has launched its aprevo Technology Platform for cervical fusion surgeries in the U.S., with early clinical data to be presented at the CSRS Annual Meeting [1][2] Company Overview - Carlsmed is a medical technology company focused on AI-enabled personalized spine surgery solutions, aiming to improve outcomes and reduce healthcare costs [5] Product Details - The aprevo Cervical Interbody System enhances Carlsmed's personalized spine platform, utilizing AI-driven preoperative planning and 3D-printed, patient-specific implants [2] - The cervical system builds on the success of the aprevo lumbar platform, which has shown lower complication rates and fewer revision surgeries compared to standard stock implants [2] Market Context - Over 370,000 cervical fusion surgeries were performed in the U.S. this year, indicating a growing need for technologies that improve alignment and anatomical fit, especially for patients with poor bone quality [3] - Early clinical experience indicates efficient workflow integration and precise implant fit, achieving planned sagittal and coronal alignment goals [3] Clinical Feedback - Positive clinical feedback has been received from the first 50+ cases, with strong reimbursement support and increasing demand for the cervical system [4] - Experts highlight the importance of personalization in cervical spine surgery, noting that the aprevo Cervical system allows for three-dimensional preoperative planning tailored to each patient's anatomy [4]